Skip to content

OPMIS

Open Randomized Cluster Clinical Trial of Community Distribution of Oral Misoprostol for Prevention of Post Partum Haemorrhage In Uganda

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201302000466116
Enrollment
4500
Registered
2012-11-27
Start date
2011-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth POST PARTUM HAEMORRHAGE

Interventions

USING VILLAGE HEALTH TEAMS AND ALONG CLEAN DELIVERY KITS
Health facility distribution of Misoprostol

Sponsors

PACE
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: At the individual level, the study included pregnant women at 28 weeks (7months) or more of gestation determined from LNMP or clinical examination, had to be residents of Mubende or Mityana districts, above 18 years of age and anticipating uncomplicated vaginal delivery. Only women who gave informed written consent were included in the study. At the cluster level, the study included parishes projected to have at least 100 births within the study period.

Exclusion criteria

Exclusion criteria: The study excluded pregnant women with diagnosed multiple pregnancy, chronic medical conditions and reported hypersensitivity to prostaglandins or inability to give informed consent (e.g. mental health illness), as assessed by the recruiting research assistant

Design outcomes

Primary

MeasureTime frame
The proportion (Percentages) of women receiving misoprostol who correctly self-administered the tablets after delivery in the three arms.

Secondary

MeasureTime frame
Acceptability of community distribution of misoprostol

Countries

Uganda

Contacts

Public ContactWILSON;FRANCIS MUBIRU;KIGONGO

DIRECTOR OF HEALTH SERVICES MUBENDE DISTRICT;DIRECTOR OF HEALTH SERVICES MITYANA DISTRICT

mubiruwh@yahoo.co.uk;Kigongo.francis@yahoo.com+256 772670556;+256 772434792

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026